IBDEI2W8 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46152,0)
 ;;=H52.213^^176^2300^2
 ;;^UTILITY(U,$J,358.3,46152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46152,1,3,0)
 ;;=3^Astigmatism,Irregular,Bilateral
 ;;^UTILITY(U,$J,358.3,46152,1,4,0)
 ;;=4^H52.213
 ;;^UTILITY(U,$J,358.3,46152,2)
 ;;=^5006272
 ;;^UTILITY(U,$J,358.3,46153,0)
 ;;=H52.223^^176^2300^3
 ;;^UTILITY(U,$J,358.3,46153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46153,1,3,0)
 ;;=3^Astigmatism,Regular,Bilateral
 ;;^UTILITY(U,$J,358.3,46153,1,4,0)
 ;;=4^H52.223
 ;;^UTILITY(U,$J,358.3,46153,2)
 ;;=^5006276
 ;;^UTILITY(U,$J,358.3,46154,0)
 ;;=H40.1113^^176^2300^49
 ;;^UTILITY(U,$J,358.3,46154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46154,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,46154,1,4,0)
 ;;=4^H40.1113
 ;;^UTILITY(U,$J,358.3,46154,2)
 ;;=^5138539
 ;;^UTILITY(U,$J,358.3,46155,0)
 ;;=H40.1123^^176^2300^50
 ;;^UTILITY(U,$J,358.3,46155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46155,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage,Left Eye
 ;;^UTILITY(U,$J,358.3,46155,1,4,0)
 ;;=4^H40.1123
 ;;^UTILITY(U,$J,358.3,46155,2)
 ;;=^5138544
 ;;^UTILITY(U,$J,358.3,46156,0)
 ;;=H35.3110^^176^2300^39
 ;;^UTILITY(U,$J,358.3,46156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46156,1,3,0)
 ;;=3^Nonexudative ARMD,Right Eye
 ;;^UTILITY(U,$J,358.3,46156,1,4,0)
 ;;=4^H35.3110
 ;;^UTILITY(U,$J,358.3,46156,2)
 ;;=^5138500
 ;;^UTILITY(U,$J,358.3,46157,0)
 ;;=H35.3120^^176^2300^38
 ;;^UTILITY(U,$J,358.3,46157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46157,1,3,0)
 ;;=3^Nonexudative ARMD,Left Eye
 ;;^UTILITY(U,$J,358.3,46157,1,4,0)
 ;;=4^H35.3120
 ;;^UTILITY(U,$J,358.3,46157,2)
 ;;=^5138505
 ;;^UTILITY(U,$J,358.3,46158,0)
 ;;=H35.3210^^176^2300^26
 ;;^UTILITY(U,$J,358.3,46158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46158,1,3,0)
 ;;=3^Exudative ARMD,Right Eye
 ;;^UTILITY(U,$J,358.3,46158,1,4,0)
 ;;=4^H35.3210
 ;;^UTILITY(U,$J,358.3,46158,2)
 ;;=^5138520
 ;;^UTILITY(U,$J,358.3,46159,0)
 ;;=H35.3220^^176^2300^25
 ;;^UTILITY(U,$J,358.3,46159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46159,1,3,0)
 ;;=3^Exudative ARMD,Left Eye
 ;;^UTILITY(U,$J,358.3,46159,1,4,0)
 ;;=4^H35.3220
 ;;^UTILITY(U,$J,358.3,46159,2)
 ;;=^5138524
 ;;^UTILITY(U,$J,358.3,46160,0)
 ;;=E11.3291^^176^2300^15
 ;;^UTILITY(U,$J,358.3,46160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46160,1,3,0)
 ;;=3^DM Type 2 w/ Mild NPDR w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,46160,1,4,0)
 ;;=4^E11.3291
 ;;^UTILITY(U,$J,358.3,46160,2)
 ;;=^5138335
 ;;^UTILITY(U,$J,358.3,46161,0)
 ;;=E11.3292^^176^2300^16
 ;;^UTILITY(U,$J,358.3,46161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46161,1,3,0)
 ;;=3^DM Type 2 w/ Mild NPDR w/o Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,46161,1,4,0)
 ;;=4^E11.3292
 ;;^UTILITY(U,$J,358.3,46161,2)
 ;;=^5138336
 ;;^UTILITY(U,$J,358.3,46162,0)
 ;;=E11.3391^^176^2300^17
 ;;^UTILITY(U,$J,358.3,46162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46162,1,3,0)
 ;;=3^DM Type 2 w/ Mod NPDR w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,46162,1,4,0)
 ;;=4^E11.3391
 ;;^UTILITY(U,$J,358.3,46162,2)
 ;;=^5138343
 ;;^UTILITY(U,$J,358.3,46163,0)
 ;;=E11.3392^^176^2300^18
 ;;^UTILITY(U,$J,358.3,46163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46163,1,3,0)
 ;;=3^DM Type 2 w/ Mod NPDR w/o Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,46163,1,4,0)
 ;;=4^E11.3392
